|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 143.26 USD | +8.07% |
|
+12.90% | +67.38% |
| 10-02 | UBS Adjusts GRAIL Price Target to $175 From $105, Maintains Buy Rating | MT |
| 10-02 | Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms | RE |
| Market Cap | 6.4B 5.69B 5.3B 4.83B 9.12B 616B 9.2B 64.26B 24.91B 314B 24.02B 23.5B 1,010B | P/E 2026 * |
-14.3x | P/E 2027 * | -13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 5.8B 5.15B 4.8B 4.38B 8.26B 558B 8.33B 58.2B 22.56B 285B 21.76B 21.28B 915B | EV / Sales 2026 * |
32.1x | EV / Sales 2027 * | 26.8x |
| Free-Float |
95% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GRAL | Delayed | |
CBOE
| GRAL | Real-time | |
|
Tradegate
| NL0 | Real-time | |
|
Mexican S.E.
| GRAL * | End-of-day quote | |
|
Boerse Muenchen
| NL0 | Real-time | |
|
Deutsche Boerse AG
| NL0 | Delayed | |
|
Börse Stuttgart
| NL0 | End-of-day quote | |
|
Börse Stuttgart
| NL0 | Delayed |
Last Transcript: GRAIL, Inc.
| 1 day | +8.07% | ||
| 1 week | +12.90% | ||
| Current month | +2.24% | ||
| 1 month | +77.83% | ||
| 3 months | +107.29% | ||
| 6 months | +160.52% | ||
| Current year | +67.38% |
| 1 week | 126.74 |  | 151.46 |
| 1 month | 73.46 | | 151.46 |
| Current year | 41.5 | | 151.46 |
| 1 year | 41.5 | | 151.46 |
| 3 years | 12.33 | | 151.46 |
| 5 years | 12.33 | | 151.46 |
| 10 years | 12.33 | | 151.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joshua Ofman
CEO | Chief Executive Officer | 62 | 2026-05-31 |
Aaron Freidin
DFI | Director of Finance/CFO | 47 | 2021-10-31 |
Harpal S. Kumar
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Joshua Ofman
BRD | Director/Board Member | 62 | 2026-03-11 |
William Chase
BRD | Director/Board Member | 58 | 2024-06-20 |
Steven Mizell
BRD | Director/Board Member | 66 | 2024-06-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/21/26 | Exercice | Chief Executive Officer | 114,356 | 0.2665% | ||
| 9/21/26 | Sell | Chief Financial Officer | -4,100 | 0.0096% | ||
| 8/27/26 | Sell | Chief Executive Officer | -5,000 | 0.0117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.07% | +12.90% | +121.32% | - | 6.4B | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 57.39B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.64B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.29B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.5B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 28.53B | |
| +0.05% | -1.64% | -7.28% | -14.06% | 24.34B | |
| Average | +0.60% | +0.76% | +61.08% | +120.28% | 39.69B | |
| Weighted average by Cap. | +0.25% | -0.62% | +59.77% | +129.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 181M 161M 150M 137M 258M 17.41B 260M 1.82B 704M 8.88B 679M 664M 28.54B | 227M 201M 188M 171M 323M 21.82B 326M 2.28B 882M 11.13B 851M 832M 35.77B |
| Net income | -428M -380M -354M -323M -610M -41.2B -615M -4.3B -1.67B -21.01B -1.61B -1.57B -67.53B | -442M -393M -366M -334M -630M -42.59B -636M -4.44B -1.72B -21.72B -1.66B -1.62B -69.8B |
| Net Debt | -604M -537M -500M -456M -860M -58.14B -868M -6.06B -2.35B -29.65B -2.27B -2.22B -95.3B | -319M -284M -265M -241M -455M -30.76B -459M -3.21B -1.24B -15.69B -1.2B -1.17B -50.41B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | US$143.26 | +8.07% | 875,335 |
| 26-10-01 | US$132.56 | -5.40% | 1,090,157 |
| 26-09-30 | US$140.12 | +2.60% | 1,923,794 |
| 26-09-29 | US$136.57 | +2.97% | 922,969 |
| 26-09-28 | US$132.63 | +4.52% | 1,110,431 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GRAL Stock
Select your edition
All financial news and data tailored to specific country editions
